Nurix’s Chief Scientific Officer, Gwenn Hansen, Ph.D., will discuss how Nurix is deploying its innovative targeted protein modulation platform to develop novel therapeutics in a presentation at the SMART Symposium on Wednesday, November 13, 2024, at 2:00 p.m. CST in Shenzhen, China. Learn more here: https://bit.ly/40wMGcq
